Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2760 Target Snapshot

Sphingomyelin phosphodiesterase · SINGLE PROTEIN · Homo sapiens

13,572Compounds
41Assays
2Approved Drugs
214.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P17405. Use UniProt P17405 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P17405 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sphingomyelin phosphodiesterase as ChEMBL target CHEMBL2760, mapped to UniProt P17405. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sphingomyelin phosphodiesterase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2760
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P17405
Sphingomyelin phosphodiesterase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sphingomyelin phosphodiesterase is the right protein anchor across sources, using UniProt P17405 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSphingomyelin phosphodiesterase
UniProt AccessionP17405
Component TypeProtein
Sequence Length631 aa

Sphingomyelin phosphodiesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sphingomyelin phosphodiesterase, mapped to UniProt P17405. Sequence length is 631 aa.

Mapped IDP17405
Review nameSphingomyelin phosphodiesterase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC50212.0
KI2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4163007 7.7 IC50 20.0 Preclinical
CHEMBL4553570 7.7 IC50 20.0 Preclinical
CHEMBL5288063 7.7 IC50 20.0 Preclinical
CHEMBL4176817 7.16 IC50 70.0 Preclinical
CHEMBL4167088 6.54 IC50 290.0 Preclinical
CHEMBL4161092 6.52 IC50 300.0 Preclinical
CHEMBL5434322 6.52 IC50 300.0 Preclinical
CHEMBL4172326 6.51 IC50 310.0 Preclinical
CHEMBL4551503 6.5 IC50 320.0 Preclinical
CHEMBL4464117 6.47 IC50 340.0 Preclinical
Distribution

pChEMBL Value Distribution

36
5.0
17
5.5
22
6.0
5
6.5
1
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

42
Total Assays
151
Tested Compounds
2
Assay Types
Binding — 40 assays, 151 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 27 101 5.3
cell-based format 8 0
assay format 4 49 5.1
cell membrane format 1 1 5.2
Functional — 2 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine